QILU PHARM CO LTD FDA Approval ANDA 204890

ANDA 204890

QILU PHARM CO LTD

FDA Drug Application

Application #204890

Application Sponsors

ANDA 204890QILU PHARM CO LTD

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002

Application Products

001INJECTABLE;IV (INFUSION)EQ 100MG BASE/1VILE0PEMETREXEDPEMETREXED
002POWDER;INTRAVENOUSEQ 500MG BASE/VIAL0PEMETREXEDPEMETREXED DISODIUM

FDA Submissions

UNKNOWN; ORIG1TA2017-05-19

Submissions Property Types

ORIG1Null42

TE Codes

001PrescriptionAP
002PrescriptionAP

CDER Filings

QILU PHARM CO LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204890
            [companyName] => QILU PHARM CO LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"PEMETREXED","activeIngredients":"PEMETREXED","strength":"EQ 100MG BASE\/1VILE","dosageForm":"INJECTABLE;IV (INFUSION)","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/19\/2017","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-05-19
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.